Faculty of Health, Education & Life Sciences, Birmingham City University, City South Campus, Westbourne Road, Edgbaston, Birmingham B15 3TN, UK.
Dietetic Department, Birmingham Women's and Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.
Nutrients. 2021 Nov 8;13(11):3977. doi: 10.3390/nu13113977.
Patients with phenylketonuria (PKU) are reliant on special low protein foods (SLPFs) as part of their dietary treatment. In England, several issues regarding the accessibility of SLPFs through the national prescribing system have been highlighted. Therefore, prescribing patterns and expenditure on all SLPFs available on prescription in England ( = 142) were examined. Their costs in comparison to regular protein-containing ( = 182) and products ( = 135) were also analysed. Similar foods were grouped into subgroups ( = 40). The number of units and costs of SLPFs prescribed in total and per subgroup from January to December 2020 were calculated using National Health Service (NHS) Business Service Authority (NHSBSA) ePACT2 (electronic Prescribing Analysis and Cost Tool) for England. Monthly patient SLPF units prescribed were calculated using patient numbers with PKU and non-PKU inherited metabolic disorders (IMD) consuming SLPFs. This was compared to the National Society for PKU (NSPKU) prescribing guidance. Ninety-eight percent of SLPF subgroups ( 39/40) were more expensive than regular and food subgroups. However, costs to prescribe SLPFs are significantly less than theoretical calculations. From January to December 2020, 208,932 units of SLPFs were prescribed (excluding milk replacers), costing the NHS £2,151,973 (including milk replacers). This equates to £962 per patient annually, and prescribed amounts are well below the upper limits suggested by the NSPKU, indicating under prescribing of SLPFs. It is recommended that a simpler and improved system should be implemented. Ideally, specialist metabolic dietitians should have responsibility for prescribing SLPFs. This would ensure that patients with PKU have the necessary access to their essential dietary treatment, which, in turn, should help promote dietary adherence and improve metabolic control.
苯丙酮尿症(PKU)患者依赖特殊低蛋白食物(SLPFs)作为其饮食治疗的一部分。在英国,已经强调了通过国家处方系统获得 SLPF 的可及性存在几个问题。因此,检查了在英格兰通过处方提供的所有可处方 SLPF(= 142)的开方模式和支出。还分析了它们与常规含蛋白质的产品(= 182)和食品(= 135)的成本比较。相似的食物被分为亚组(= 40)。使用英格兰国家卫生服务局(NHS)商业服务局(NHSBSA)的电子处方分析和成本工具(ePACT2)计算了 2020 年 1 月至 12 月期间总共和每个亚组开出的 SLPF 单位和费用。使用患有 PKU 和非 PKU 遗传性代谢疾病(IMD)并消耗 SLPF 的患者人数计算了每月患者 SLPF 单位的处方量。这与全国 PKU 协会(NSPKU)的处方指南进行了比较。98%的 SLPF 亚组(39/40)比常规和食品亚组都昂贵。然而,开具 SLPF 的处方成本明显低于理论计算。2020 年 1 月至 12 月,共开出 208932 单位的 SLPF(不包括代乳品),NHS 花费 2151973 英镑(包括代乳品)。这相当于每个患者每年 962 英镑,开方量远低于 NSPKU 建议的上限,表明 SLPF 的处方不足。建议实施一个更简单和改进的系统。理想情况下,应将特殊代谢营养师负责开具 SLPF 处方。这将确保 PKU 患者获得必要的基本饮食治疗,从而有助于促进饮食依从性并改善代谢控制。